메뉴 건너뛰기




Volumn 16, Issue 9, 2008, Pages 5277-5284

Rationally designed PKA inhibitors for positron emission tomography: Synthesis and cerebral biodistribution of N-(2-(4-bromocinnamylamino)ethyl)-N-[11C]methyl-isoquinoline-5-sulfonamide

Author keywords

Carbon 11; H 89; H 9; PET; Protein kinase A; Signal transduction

Indexed keywords

CYCLIC AMP DEPENDENT PROTEIN KINASE; CYCLIC AMP DEPENDENT PROTEIN KINASE INHIBITOR; DIAMINE DERIVATIVE; ISOQUINOLINE 5 SULFONYL CHLORIDE; N (2 AMINOETHYL) 5 ISOQUINOLINESULFONAMIDE; N (2 AMINOETHYL) N METHYL ISOQUINOLINE 5 SULFONAMIDE; N [2 (4 BROMOCINNAMYLAMINO)ETHYL] 5 ISOQUINOLINESULFONAMIDE; N [2 (4 BROMOCINNAMYLAMINO)ETHYL]N METHYL ISOQUINOLINE 5 SULFONAMIDE C 11; N [2 [BIS(4 BROMOCINNAMYL)AMINO]ETHYL] N METHYL ISOQUINOLINE 5 SULFONAMIDE; N METHYLETHYLENEDIAMINE; QUINOLINE DERIVATIVE;

EID: 43049097156     PISSN: 09680896     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bmc.2008.03.013     Document Type: Article
Times cited : (11)

References (37)


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.